The E5 oncoprotein of the human papillomavirus type 16 (HPV16 E5) cooperates in cervical carcinogenesis and in epithelial transformation deregulating cell growth, survival and differentiation through the modulation of growth factor receptors. Among the epithelial receptor tyrosine kinases, the keratinocyte growth factor receptor/ fibroblast growth factor receptor 2b (KGFR/FGFR2b) is a major paracrine mediator of epithelial homeostasis and appears to have an unique and unusual role in epithelial tissues, exerting a tumor-suppressive function in vitro and in vivo. With the aim to better elucidate the molecular events involved in the pathological activity of 16E5, we investigated if the viral protein would be able to affect the KGFR expression, signaling and turnover by interference with its degradative and recycling endocytic pathways. Quantitative reverse transcriptase-PCR and biochemical approaches on human keratinocytes transfected with 16E5-HA showed that E5 protein is able to induce KGFR down-modulation at both transcript and protein levels. Immunofluorescence microscopy in double-transfected cells expressing both E5 and KGFR revealed that the viral protein alters the receptor endocytic trafficking and triggers its endosomal sorting to the indirect juxtanuclear recycling pathway. The shift from lysosomal degradation to recycling at the plasma membrane correlates with a reduced phosphorylation of the fibroblast growth factor receptor substrate-2a tyrosine 196, the major docking site for Grb2-Cbl complexes responsible for receptor ubiquitination and degradation. 5 0 -Bromo-deoxyuridine incorporation assay demonstrated that expression of 16E5 induces a decrease in the growth response to the receptor ligands as a consequence of KGFR down-modulation, suggesting that 16E5 might have a role on HPV infection in perturbing the KGFR-mediated physiological behavior of confluent keratinocytes committed to differentiation.
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Introduction
The E5 protein of the human papillomavirus type 16 (HPV16 E5) is a small, weakly oncogenic protein prevalently localized in the endoplasmic reticulum membranes (Conrad et al., 1993) , which cooperates with E6 and E7 in cervical carcinogenesis and epithelial transformation deregulating cell growth, survival and differentiation (for a recent review, see Moody and Laimins, 2010) . In addition, 16E5 represents a multifunctional protein able to inhibit the host immune response decreasing the exposition of the antigenpresenting major histocompatibility complex class I and II at the cell surface (Zhang et al., 2003; Ashrafi et al., 2006) and to interfere with cell-cell communication (Oelze et al., 1995) .
The oncogenic activity not only of 16E5 but also of other E5 proteins encoded by different papillomaviruses appears to be correlated to their capacity to affect the function of receptor tyrosine kinases such as PDGFR (Petti et al., 1991; Talbert-Slagle and DiMaio, 2008) , EGFR (Pim et al., 1992; Straight et al., 1993; Crusius et al., 1998; Pedroza-Saavedra et al., 2010) , ErbB2 (Crusius et al., 1998) and ErbB4 (Chen et al., 2007) . In the case of EGFR, 16E5 is able to alter the intracellular pathways mediating EGF signaling, such as extracellular signal-regulated kinase-1 and -2 (Crusius et al., 1997; Zhang et al., 2002) . This viral protein appears to enhance the receptor signaling prevalently by deregulating its endocytic trafficking through different mechanisms: in fact, 16E5 is known to bind the 16-Kda subunit of the vacuolar H þ -ATPase (Rodriguez et al., 2000) , inhibiting endosomal acidification and EGFR degradation and inducing receptor recycling (Straight et al., 1995) . Alternatively, it may block the sorting from early to late endosomes perturbing the actin cytoskeleton (Thomsen et al., 2000) . More recently, however, it has been proposed that 16E5 affects the EGF endocytic trafficking altering the endosome fusion through a pH-independent and cytoskeletonindependent mechanism (Suprynowicz et al., 2010) . In addition, it has been also demonstrated that E5 protein is able to form a complex with the EGFR and to enhance its ligand-dependent signaling by disrupting EGFR/c-Cbl interaction and consequently decreasing the ubiquitin-mediated receptor degradation (Zhang et al., 2005) .
Among the epithelial growth factors, the keratinocyte growth factor (KGF/FGF7) and the fibroblast growth factor 10 (FGF10/KGF2) are major paracrine mediators of proliferation, differentiation, survival and migration of epithelial cells (Finch et al., 1989; Marchese et al., 1990 Marchese et al., , 2001 Ceccarelli et al., 2007; Lotti et al., 2007) . Both KGF and FGF10 bind to and activate exclusively the keratinocyte growth factor receptor (KGFR/FGFR2b), a splicing transcript variant of FGFR2 expressed exclusively on epithelial cells (Miki et al., 1991) . In contrast to most of the growth factor receptors, KGFR appears to have a unique and unusual role in epithelial tissues, exerting a tumor-suppressive function in vitro and in vivo (Feng et al., 1997; Zhang et al., 2001; Grose et al., 2007 and reviewed in Turner and Grose, 2010) . Similarly to other receptor tyrosine kinases, KGFR signaling is attenuated and regulated by clathrin-mediated endocytosis (Belleudi et al., 2006 (Belleudi et al., , 2007 . Our previous studies on the endocytic pathways followed by KGFR have demonstrated the opposite endosomal sorting of the receptor triggered by the two ligands: in fact, KGF targets the receptor to the degradative pathway, whereas FGF10 induces KGFR sorting to the indirect recycling route (Belleudi et al., 2007 (Belleudi et al., , 2009 . Therefore, based on its crucial physiological role in the epithelial homeostasis, KGFR represents a possible target molecule for the biological activity of HPV16 E5, which may affect receptor expression, signaling and turnover. In addition, as KGFR is characterized by the peculiar endocytic behavior in response to different ligands and HPV16 E5 protein is able to modulate the epithelial receptor tyrosine kinase signaling altering the endocytic trafficking, we investigated if 16E5 protein expression would be able to interfere with the two alternative KGFR endocytic pathways and how this possible interference could affect cell proliferation.
Results

HPV 16E5 expression does not affect KGFR internalization but alters its endocytic trafficking
To investigate the effects of HPV 16E5 expression on KGFR endocytosis, we first assessed the viral protein expression and its intracellular localization following transfection in the human HaCaT keratinocytes. Cells were transiently transfected using a pCIneo E5-HA expression vector (Ashrafi et al., 2005) (HaCaT E5) (a) HaCaT cells were transiently transfected using pCI-neo-E5-HA expression vector (HaCaT E5) or using the empty vector alone (HaCaT pCI-neo). After 24 h from transfection, 16E5 expression was assessed by qualitative PCR (left panel, top) and b-actin mRNA was used as internal control: while the 16E5 band is visible only in HaCaT E5 cells, the band corresponding to actin is detected in both RT þ samples. antibody showed staining of the nuclear membrane and of cytoplasmic reticular structures probably corresponding to the endoplasmic reticulum, as expected (Conrad et al., 1993) (Figure 1a , bottom panel on the left). Double immunofluorescence analysis, performed by serial optical sectioning followed by three-dimensional reconstruction and using specific markers of the different intracellular compartments, confirmed that 16E5 colocalizes mainly with the specific endoplasmic reticulum marker calreticulin, while only a minor colocalization was observed with the marker of the Golgi complex giantin or with the mitochondrial tracer MitoTracker (Figure 1b (Figure 2a , right panel), suggesting that 16E5 protein is able to induce KGFR transcriptional down-modulation. To evaluate the receptor down-modulation at the protein level, western blot analysis was performed in HaCaT KGFR and HaCaT KGFR/E5 cells, as well as in HaCaT pCI-neo control cells, using anti-Bek antibody, which recognizes both FGFR2 splicing variants FGFR2b/KGFR and FGFR2c, and the equal loading was assessed with anti-actin antibody. As shown in Figure 2b , the band at the molecular weight of 140 KDa corresponding to KGFR, not visible in the control cells because of the low amount of endogenous receptors in pre-confluent keratinocytes (Capone et al., 2000) , appeared decreased in HaCaT KGFR/E5 doubletransfected cells compared with HaCaT KGFR cells, confirming the KGFR down-modulation induced by 16E5 expression at both transcript and protein levels.
Then we analyzed if 16E5 localization could be modified during KGFR endocytosis: to this aim, HaCaT KGFR/E5 and HaCaT KGFR cells were treated with the anti-Bek antibody, which recognizes the extracellular portion of KGFR and which does not compete with the ligands for binding to the receptor, and with KGF for 1 h at 4 1C before warming to 37 1C for 30 min in order to induce a synchronous wave of KGFR endocytosis. 16E5 localization was analyzed by immunofluorescence using anti-HA antibody as above. Nuclei were stained with 4,6-diamidino-2-phenylindole. On KGF treatment, while the receptor staining was drastically redistributed from the cell surface to intracellular spots (Figure 2c ) as occurring during liganddependent internalization, the E5 signal appeared distributed similarly than in untreated cells, suggesting that the localization of the viral protein is not affected by the induction of KGFR endocytosis (Figure 2c ). Interestingly, in co-transfected cells overexpressing both E5 and KGFR, the endocytic dots corresponding to internalized receptors appeared more peripheral compared with the expected (Belleudi et al., 2007) perinuclear and clustered pattern observed in cells overexpressing KGFR alone (Figure 2c) . Thus, although the early events of KGFR internalization seem not affected, 16E5 protein expression alters the KGF-induced endocytic trafficking of the receptor.
HPV16 E5 expression inhibits the KGFR transport to the endocytic degradative pathway As 16E5 expression is able to interfere with the endocytic degradative sorting of receptor tyrosine kinases (RTKs) and because our present observations indicate that 16E5 expression is able to alter the endocytic trafficking of KGFR, we wondered if and how the expression of the viral protein could interfere with the two alternative endocytic trafficking of KGFR induced by its specific ligands KGF and FGF10 (Belleudi et al., 2007) . In particular, to search for possible differential sorting of receptors destined to recycling or degradation in cells expressing 16E5, we focused our attention on the late steps of KGFR internalization. To selectively follow the internalizing receptors and to induce a synchronous wave of KGFR endocytosis, HaCaT KGFR/E5 and HaCaT KGFR cells were treated with the anti-Bek antibody as above and with KGF or FGF10 for 1 h at 4 1C before warming to 37 1C for 1 h. Cells were also incubated in the presence of LysoTracker-Red to identify lysosomes or with transferrin-Texas Red (Tf-TxRed) for 1 h at 37 1C to identify the juxtanuclear recycling compartment. Immunofluorescence observation at low ( Figure 3a ) and high ( Figure 3b 
16E5 expression induces KGFR recycling to the plasma membrane
It has been demonstrated that 16E5 expression causes not only the inhibition of EGFR degradation but also the enhancement of receptor recycling to the plasma membrane (Straight et al., 1993 Figure 3 16E5 inhibits the KGF-induced degradative pathway of KGFR, but does not affect the receptor recycling pathway induced by FGF10. (a, b) HaCaT KGFR/E5 and HaCaT KGFR cells were serum starved, treated with the anti-Bek antibody as above and with KGF or FGF10 for 1 h at 4 1C before warming to 37 1C for 1 h to allow synchronous receptor internalization. The late endosomal/ lysosomal compartment and the juxtanuclear recycling compartment were identified by incubation for 1 h at 37 1C with LysoTrackerred or with Tf-TxRed respectively. Double immunofluorescence images at low magnification (a) show that, after KGF treatment, the KGFR punctate signal remain peripheral in cells overexpressing KGFR and 16E5, but clustered in perinuclear structures in cells overexpressing KGFR alone (a, arrows). In contrast, after FGF10 treatment, the localization of the KGFR signal was peripheral in both co-transfected and singly transfected cells (a). Images at high magnification show that, on KGF treatment, in HaCaT KGFR/E5 cells the receptor staining colocalizes with Tf-TxRed in the recycling compartment and does not overlap with LysoTracker in perinuclear lysosomes, as observed in HaCaT KGFR cells (b) . In contrast, on FGF10 treatment, the receptor signal colocalizes with Tf-TxRed in both HaCaT KGFR and HaCaT KGFR/E5 cells (b). Bars: 10 mm. (c) Quantitative analysis of the percentage of colocalization was performed by serial optical sectioning and three-dimensional (3D) reconstruction as above. Results are expressed as mean values±s.e. (standard errors); the percentage of colocalization was calculated analyzing a minimum of 40 cells for each treatment randomly taken from three independent experiments. Student's t-test was performed and significance level has been defined as described in materials and methods: *Po0.005 vs KGF-treated HaCaT KGFR cells, **Po0.005 vs FGF10-treated HaCaT KGFR cells and ***Po0.0001 vs KGF-treated HaCaT KGFR cells.
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(FITC)-conjugated wheat germ agglutinin at 4 1C before fixation and permeabilization. Quantitative immunofluorescence analysis of the KGFR staining on the plasma membrane was then performed by evaluation of the extent of colocalization of the receptor signal with wheat germ agglutinin-FITC. In HaCaT KGFR/E5, a very low percentage of receptor staining colocalized with wheat germ agglutinin after 1 h of warming to 37 1C, while reappearance of internalized KGFR on the cell surface was evident after 4 h (Figures 4a and b) . In contrast, very limited colocalization was found in
HaCaT KGFR cells either after 1 or 4 h of warming, as expected (Belleudi et al., 2009) (Figures 4a and b) . The slow kinetics of the receptor reappearance at the plasma membrane observed on KGF stimulation in cells expressing the 16E5 protein suggests that the receptor could be sorted to the slow indirect recycling pathway, which implies intracellular traffic through the juxtanuclear compartment.
To compare in parallel conditions the endocytic traffic of KGFR in the presence of 16E5 with the well-known recycling pathway followed by EGFR HPV16 E5 impairs KGFR/FGFR2b expression and traffic F Belleudi et al (Straight et al., 1993 (Straight et al., , 1995 , we treated HaCaT E5 cells with anti-EGFR monoclonal antibody and with EGF for 1 h at 4 1C before warming to 37 1C for 1 or 4 h as above. Double immunofluorescence analysis with anti-HA antibody showed, as expected, EGFR recycling to the plasma membrane in HA-positive HaCaT E5, which was clearly visible already after 1 h of warming, indicating a more rapid kinetics of receptor recycling compared with that of KGFR. As expected, in HAnegative non-transfected HaCaT cells, among the transfected ones, the EGFR signal appeared clustered in perinuclear structures after 1 h of warming and was mostly undetectable after 4 h because of receptor degradation (Figure 4a , bottom panels).
16E5 expression inhibits lysosomal degradation of KGFR inducing a qualitatively different phosphorylation of the receptor substrate FRS2a
To verify whether 16E5 expression could inhibit the KGFR lysosomal downregulation, we analyzed the kinetics of KGFR degradation in double-transfected HaCaT KGFR/E5 cells compared with HaCaT KGFR. Cells were pretreated with cycloheximide to block KGFR neosynthesis, then incubated with KGF at 37 1C for different time points and the total amount of KGFR protein present in the cell lysates was detected by western blot. Again, the receptor protein levels were lower in HaCaT KGFR/E5 double-transfected cells compared with HaCaT KGFR cells, confirming the KGFR down-modulation induced by 16E5 expression at both transcript and protein levels. Despite this E5-induced receptor down-modulation, the results showed that the expected (Belleudi et al., 2007 (Belleudi et al., , 2009 ) progressive and drastic decrease in the band corresponding to KGFR after 4 and 8 h of treatment with KGF observed in HaCaT KGFR cells (Figure 5a ) was not detectable in HaCaT KGFR/E5 cells, in which the receptor band remained unmodified up to 4 h on ligand-treatment and only partially decreased after 8 h, as a consequence of constitutive turnover (Figure 5a ). In fact, in both HaCaT KGFR and HaCaT KGFR/E5 unstimulated cells, the decrease in the band after 8 h of treatment with cycloheximide reflects constitutive turnover of the protein (Figure 5a ). Thus, expression of the E5 protein is able to induce a block of receptor degradation in response to the ligand. To investigate whether 16E5 expression could redirect the KGF-induced endocytic trafficking from the degradative to the slow recycling pathway inducing an inefficient recruitment of the Grb2/c-Cbl complex to the KGFR substrate fibroblast growth factor receptor substrate 2 (FRS2) (Gotoh, 2008 ), we analyzed the phosphorylation level of the FRS2a tyrosine 196, which represents the principal docking site for Grb2 (Kouhara et al., 1997) . In fact, we have recently demonstrated that the phosphorylation level of this tyrosine site on FRS2a correlates with the different KGFR ubiquitination, degradation and endocytic fate in response to the two alternatively ligands KGF and FGF10 (Belleudi et al., 2007) . To this aim, HaCaT KGFR/E5 and HaCaT KGFR cells were serum starved for 12 h, treated with KGF for 10 min at 37 1C and then lysed. Western blot analysis using anti-pFRS2 Y196 showed that the tyrosine 196 residue was less efficiently phosphorylated in cells expressing the E5 protein (Figure 5b ). Anti-FRS2 and anti-actin antibodies were used for equal loading control (Figure 5b) . Parallel western blot analysis using anti-phosphotyrosine antibody showed that the fold increase in phosphorylation of the band at the molecular weight of 140 Kda, corresponding to the activated receptor, was comparable in singly or doubly transfected cells (Figure 5c ), suggesting that the expression of E5 modifies only qualitatively, but not quantitatively, the ligand-dependent KGFR signaling. Taken together these results indicate that, in cells expressing the 16E5 protein, the block of the KGFR progression toward the degradative endocytic pathway on KGF stimulation is correlated to a less efficient c-Cbl recruitment to the activated receptors as a consequence of a reduced phosphorylation of the FRS2a tyrosine 196, which affects ubiquitination and degradation (Belleudi et al., 2007) .
16E5 expression reduces the proliferative response to KGFR activation
We have previously demonstrated that the recycling endocytic pathway followed by KGFR on FGF10 stimulation correlates with the higher mitogenic activity exerted by this ligand on epithelial cells compared with KGF (Marchese et al., 2001) , suggesting that the two ligands may have different functional roles through the regulation of the receptor endocytic transport (Belleudi et al., 2007) . In order to analyze the biological significance of the interference induced by 16E5 expression on the KGF-induced degradative endocytic trafficking of KGFR, we compared the proliferative response with KGF or FGF10 of HaCaT cells exogenously expressing 16E5 protein with control HaCaT cells transfected with the empty vector. Moreover, to further evaluate the functional effects of E5 on KGFR not only in cells expressing endogenous levels of the receptor, but also in cells expressing E5 in a stable manner and, therefore, in a higher number of cells, we used HaCaT cells transiently transfected with E5 (HaCaT E5) as above (Figures 6a and b) and stably transfected HaCaT pMSG E5 cells treated or not with 1 mM dexamethasone to induce E5 expression (Figures 6c  and d ). All cells were serum starved, incubated with KGF 20 ng/ml or with FGF10 20 ng/ml þ 0.3 mg/ml heparin for 24 h and with 5 0 -bromo-deoxyuridine (BrdU) during the last 1 h of incubation with the growth factors, then fixed and stained with anti-BrdU antibodies to identify DNA synthesizing proliferating cells. Cells transiently transfected with E5-HA were identified using the anti-HA antibody as above. HaCaT pCI-neo and HaCaT pMSG transfected with the empty vectors alone were used as controls. Quantitative analysis of the percentage of cells presenting BrdU-positive nuclei indicated that, in untreated conditions, the proliferation rate was higher in those cells that express E5, as HPV16 E5 impairs KGFR/FGFR2b expression and traffic F Belleudi et al expected (Leptak et al., 1991; Straight et al., 1993) (Figures 6b and d) . Consistent with the transcriptional KGFR down-modulation induced by E5 expression as described above, the percentage of BrdU-positive cells appeared only weakly increased on KGF or FGF10 treatment in both transiently or stably E5-transfected cells compared with the cells transfected with the vectors alone. However, differently from the expected higher mitogenic response to the FGF10 ligand respect to KGF occurring in the absence of E5 (Figures 6a-d) , the proliferation of cells expressing E5 stimulated by the two growth factors was comparable (Figures 6b and d) .
Thus, the transient or stable expression of 16E5 in the human keratinocytes induces KGFR down-modulation 
HPV16 E5 impairs KGFR/FGFR2b expression and traffic F Belleudi et al and consequent decrease in the proliferative response to the receptor ligands. In addition, expression of the viral protein causes impairment of the KGF-activated receptor signaling and endocytic trafficking redirecting the receptor from the degradative to the recycling pathway: the receptor reappearance at the plasma membrane renders the proliferative response to KGF comparable to that observed for FGF10.
Discussion
The oncogenic role of HPV16 E5 in epithelial transformation and malignant progression has been widely attributed to the ability of this viral protein to interfere with the endocytic pathway of signaling receptors, mainly of EGFR, either indirectly through inhibition of the endosomal acidification (Straight et al., 1995) and endosomal vesicle fusion (Suprynowicz et al., 2010) , or directly through protein interactions with the receptor tyrosine kinases (Hwang et al., 1995; Zhang et al., 2005) . As mentioned above, results obtained in previous studies from our group (Belleudi et al., 2006 (Belleudi et al., , 2007 demonstrate that KGFR endocytosis on binding of the two alternative ligands, KGF or FGF10, is clathrindependent; however, once internalized the receptors follow two different intracellular endocytic pathways: while KGF targets the receptor to the lysosomal pathway, FGF10 induces KGFR recycling to the plasma membrane. In addition, KGFR is ubiquitinated and degraded following treatment with KGF, but not with FGF10. Interestingly, the opposite endocytic trafficking and fate induced by the two ligands appear to depend on the qualitatively different tyrosine phosporylation of the FRS2, which in turn causes a different recruitment of the ubiquitin-protein ligase c-Cbl (Belleudi et al., 2007) . It has been recently proposed that FRS2 have pivotal roles in the intracellular signaling of FGFR. In fact, the FRS2 proteins (FRS2a and FRS2b) are adaptor docking proteins acting downstream of FGFR through multiple tyrosine phosphorylation sites (for a recent review, see Gotoh, 2008) . Bound in a constitutive manner to KGFR, FRS2 become phosphorylated on receptor activation. The tyrosine phosphorylated sites of FRS2a are bound either by Grb2-SOS complexes, leading to activation of the Ras/extracellular signal-regulated kinase pathway, or by Grb2-Cbl complexes, leading to ubiquitination and degradation of both FGFR and FRS2. Here, showing that the expression of E5 modifies the ligand-dependent KGFR signaling by impairment of the phosphorylation of FRS2a tyrosine 196 responsible for the interaction with Grb2-Cbl, we suggest that the block of the KGFR progression toward the degradative endocytic pathway induced by 16E5 might be correlated to a less efficient c-Cbl recruitment, which is known to affect ubiquitination and degradation (Wong et al., 2002) . Besides differential tyrosine phosphorylation at the main Grb2-Cbl docking site, other molecular mechanisms appear involved in the KGFR endosomal sorting: in fact, we have recently analyzed the role of Hrs and TSG101, two subunits of ESCRT complexes regulating the endocytic sorting of ubiquitinated receptors, and we have demonstrated that both proteins have a crucial role in the control of KGF-induced degradative endocytosis, but not in the FGF10-induced recycling of KGFR, indicating that the KGFR sorting triggered by FGF10 toward the indirect juxtanuclear recycling pathway is not only ubiquitin-independent, but also Hrs and TSG101-independent (Belleudi et al., 2007 (Belleudi et al., , 2009 . Interestingly, also the expression of 16E5 interferes selectively with the KGFR transport to the degradative pathway, but not with the receptor traffic through the recycling compartment. However, because the indirect recycling pathway is believed to be an inducible route regulated by specific sorting machinery, we cannot exclude that 16E5 protein might be directly involved in the shifting of KGFR trafficking from degradation to recycling. Recently, it has been reported that Bap31, an itinerant endoplasmic reticulum protein controlling the juxtanuclear protein trafficking (Wakana et al., 2008) , is a new binding partner of 16E5 (Regan and Laimins, 2008) suggesting that the viral protein may directly affect the intracellular transport machinery. Therefore, the KGFR endocytic traffic in the presence of 16E5 may provide a useful model for further studies directed to analyze the molecular components of the endosomal sorting complexes as well as the mechanisms controlling in an integrated manner the endocytic traffic and the receptor signaling.
In human skin, KGFRs are mostly distributed on suprabasal layers and expressed at low levels on the . Western blot analysis using anti-phosphotyrosine antibody shows that the fold increase in phosphorylation of the band at the molecular weight of 140 Kda, corresponding to the activated receptor, was comparable in singly or doubly transfected cells. The intensity of the bands was evaluated by densitometric analysis and the values from a representative experiment out of three were normalized and expressed as fold increase with respect to the untreated control value and reported in graph as mean values±s.e. (La Rochelle et al., 1995; Marchese et al., 1995) , showing a pattern opposite to that of EGFR; in addition, keratinocyte differentiation in vitro induces upregulation of KGFR expression, suggesting that this receptor may have a crucial role, distinct from other receptor tyrosine kinases such as EGFR, in the control of the proliferative/differentiative program during transition from basal to suprabasal cells (Capone et al., 2000) . As the HPVs are known to target differentiating epithelial cells (Fehrmann and Laimins, In accordance with the transcriptional KGFR down-modulation in the presence of E5 described in Figure 2, (Grose et al., 2007) . This null-mouse phenotype closely reminds that shown by the transgenic mouse for epithelial targeted HPV16 E5 expression, characterized by a similar behavior in skin carcinogenic model (Maufort et al., 2007) . Thus, we hypothesized that KGFR and HPV16 E5 could be inversely correlated in their expression and could exert opposite and interplaying roles in epithelial homeostasis and tumorigenesis. Consistent with this hypothesis, our molecular and biochemical results clearly indicate that 16E5 expression induces KGFR down-modulation at both transcript and protein levels: as HPV16 E5 protein is known to alter the expression of many genes involved in signaling pathways that are deregulated in cancer, such as cell adhesion, motility and proliferation (Kivi et al., 2008) , it is not surprising that also a major player on the balance between epithelial growth and differentiation can be affected.
HPV16 E5 impairs KGFR/FGFR2b expression and traffic
Our present results indicate also that the transcriptional down-modulation of KGFR leads to a decrease in the ligand-dependent proliferation of the 16E5 expressing keratinocytes. Again this appears not surprising since, while basal keratinocytes respond to EGFR mostly in pre-confluent conditions, it has been demonstrated by previous papers from our and other groups (Hines and Allen-Hoffmann, 1996; Capone et al., 2000) that the proliferative response to KGFR ligands requires cell confluence and commitment to differentiation. Consistent with this proposed difference in the target cells, which are stimulated by the two receptors, we believe that 16E5 might exert its biological activity: (i) increasing the growth of the most basal undifferentiated cells through enhancement of EGFR function and (ii) decreasing the physiological proliferation, and possibly differentiation, mediated by KGFR expression and signaling in the confluent and suprabasal keratinocytes. This is in agreement with the perturbing effects on epithelial growth and stratification recently observed following expression of 16E5 in organotypic raft cultures (Barbaresi et al., 2010) , which have been obtained using the same cell model system of HaCaT keratinocytes utilized throughout our study.
Materials and methods
Cells and treatments
The human keratinocyte cell line HaCaT was cultured in Dulbecco's modified Eagle's medium, supplemented with 10% fetal calf serum plus antibiotics. HaCaT cells were transiently transfected or co-transfected with pCI-neo empty vector or pCI-neo containing human KGFR cDNA or with pCI-neo containing 16E5-HA (Ashrafi et al., 2005) using jetPEI DNA Transfection Reagent (Polyplus-transfection, New York, NY, USA) according to the manufacturer's instructions. Transfected cells were collected 24 h after transfection for evaluation of protein expression and internalization assays. HaCaT cells stably transfected with the construct pMSG 16E5 (HaCaT E5) or with the empty vector (HaCaT pMSG) (kindly provided by Dr Venuti, Regina Elena Cancer Institute, Rome, Italy) were cultured in Dulbecco's modified Eagle's medium, supplemented with 10% fetal calf serum plus antibiotics and treated with 1 mM dexamethasone for 24 h to induce 16E5 expression.
For treatment with growth factors, cells were serum starved for 12 h, washed with cold medium, incubated with 100 ng/ml KGF (Upstate, Lake Placid, NY, USA), or with 100 ng/ml FGF10 (PeproTech, London, UK) þ 0.3 mg/ml heparin for 1 h at 4 1C, or with 100 ng/ml EGF (Upstate), washed with prewarmed medium and incubated at 37 1C for different times to induce KGFR endocytosis and recycling before fixation. To induce Tf internalization, cells were incubated with 50 mg/ ml Tf-TxRed (Molecular Probes, Eugene, OR, USA) at 37 1C for 1 h before fixation. To induce LysoTracker internalization, cells were incubated with 100 nM LysoTracker-Red (Molecular Probes) for 1 h at 37 1C and then fixed. For mitochondrial identification, cells were incubated with 100 nM MitoTrackerRed (Molecular Probes) for 1 h at 37 1C before fixation. To induce KGFR activation, cells were serum starved for 12 h and then incubated with 100 ng/ml KGF for 10 min at 37 1C and then lysed. For proliferation analysis, cells were serum starved and incubated with KGF 20 ng/ml or with FGF10 20 ng/ml þ 0.3 mg/ml heparin for 24 h at 37 1C before fixation. To inhibit the synthesis of proteins, cells were treated with 25 mg/ml cycloheximide (Sigma Chemicals, St Louis, MO, USA) for 4 h at 37 1C before incubation with the growth factor in presence of cycloheximide for different time points. To visualize the cell surface, plasma membranes were decorated with FITC-conjugated lectin wheat germ agglutinin (Sigma) at 4 1C before fixation and permeabilization.
For BrdU incorporation assay to evaluate DNA synthesis and cell proliferation, transfected cells treated with the growth factors as above were incubated during the last 1 h of the treatment with 100 mM BrdU (Sigma) added to the medium. Cells were then fixed in 4% formaldehyde in phosphatebuffered saline (PBS) for 30 min at 25 1C, followed by treatment with 0.1 M glycin for 20 min at 25 1C and with 0.5% HCl, 0.1% triton X-100 for additional 45 min at 25 1C to allow permeabilization. After extensive washing in PBS, cells were buffered with 0.1 M Na2B4O7 and incubated with anti-BrdU monoclonal antibody (1:50 in PBS) (Sigma) for 30 min at 25 1C, followed by goat anti-mouse immunoglobulin G-FITC (1:20 in PBS) (Cappel Research Products, Durham, NC, USA).
Immunofluorescence Cells grown on coverslips and incubated with KGF or FGF10 as above were fixed with 4% paraformaldehyde followed by treatment with 0.1 M glycine for 20 min at 25 1C and with 0.1% Triton X-100 for additional 5 min at 25 1C to allow permeabilization. Cells were then incubated with the following primary antibodies: anti-Bek polyclonal antibodies (1:50 in PBS; H-80, Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA), directed against the extracellular portion of FGFR2/ KGFR, anti-EGFR monoclonal antibody (1:100 in PBS; Ab-1, Calbiochem, Nottingham, UK), also directed against the extracellular portion of the receptor, anti-HA monoclonal antibody (1:50 in PBS; Covance, Berkeley, CA, USA), anti-HA-FITC monoclonal antibody (1:10 in PBS, Miltenyi Biotec, Auburn, CA, USA), anti-calreticulin (1:50 in PBS; Stressgen, Victoria, BC, Canada), anti-giantin polyclonal antibodies (1:50 in PBS; Covance). Nuclei were stained with 4,6-diamidino-2-phenylindole (1:10 000 in PBS; Sigma). The primary antibodies were visualized, after appropriate washing with PBS, using Quantitative analysis of the extent of colocalization was performed using Zeiss KS300 3.0 Image Processing system (Zeiss). The mean±standard error (s.e.) percentage of colocalization was calculated analyzing a minimum of 30 cells for each treatment randomly taken from three independent experiments. P-values were calculated using Student's t-test and significance level has been defined as Po0.05.
Western blot analysis
HaCaT KGFR, HaCaT KGFR/E5-HA and HaCaT pCI-neo cells were lysed in a buffer containing 50 mM HEPES pH 7.5, 150 mM NaCl, 1% glycerol, 1% Triton X-100, 1.5 mM MgCl2, 5 mM EGTA, supplemented with protease inhibitors (10 mg/ml aprotinin, 1 mM phenylmethylsulfonyl fluoride, 10 mg/ml leupeptin), and phosphatase inhibitors (1 mM sodium orthovanadate, 20 mM sodium pyrophosphate, 0.5 M NaF); 50 mg of total protein were resolved under reducing conditions by 7% sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred to reinforced nitrocellulose (BA-S 83, Schleider and Schuell, Keene, NH, USA). The membranes were blocked with 5% non-fat dry milk in PBS 0.1% tween 20, and incubated with anti-phosphotyrosine (Upstate) monoclonal antibody, anti-Bek (C-17, Santa Cruz), anti-phospho FRS2 (Y196; Cell Signaling, Danvers, MA, USA) polyclonal antibodies, or anti-actin (Sigma) monoclonal antibody, to estimate the protein equal loading, followed by enhanced chemioluminescence detection (ECL, Amersham, Alington Heights, IL, USA). The membranes were rehydrated by being washed in PBS-Tween 20, stripped with 100 mM mercaptoethanol and 2% sodium dodecyl sulfate for 30 min at 55 1C, and probed again with anti-Bek (C17) polyclonal antibodies or anti-FRS2 (Santa Cruz) monoclonal antibody.
Densitometric analysis was performed using Quantity One Program (Bio-Rad Headquarters, Hercules, CA, USA). Briefly, the signal intensity for each band was calculated and the background subtracted from experimental values. The resulting values were then normalized and expressed as fold increase respect to the control and mean values±s.e.
Primers
Oligonucleotide primers for target genes and for the housekeeping gene were chosen with the assistance of the Oligo 5.0 computer program (National Biosciences, Plymouth, MN, USA) and purchased from Invitrogen (Carlsbad, CA, USA). The following primers were used: for FGFR2b/KGFR gene: 5 0 -CAGGGGTCTCCGAGTATGAA-3 0 (sense), 5 0 -TCTAAA GGCAACCTCCGAGA-3 0 (antisense); for HPV 16E5 gene 5 0 -CGCTGCTTTTGTCTGTGTCT-3 0 (sense), 5 0 -GCGTGCA TGTGTATGTATTAAAAA-3 0 (antisense). Gel electrophoresis was used to verify the specificity of PCR amplicons. For each primer pair, we performed no-template control and no-reverse-transcriptase control (RT-negative) assays, which produced negligible signals.
RNA extraction and cDNA synthesis RNA was extracted using the TRIzol method (Invitrogen) according to the manufacturer's instructions and eluted with 0.1% diethylpyrocarbonate-treated water. Total RNA concentration was quantitated by spectrophotometry and the quality was assessed by measuring the optical density ratio at 260/280 nm. RNA samples were stored at À80 1C. After denaturation in diethylpyrocarbonate-treated water at 70 1C for 10 min, 1 mg of total RNA was used to reverse transcription using iScript cDNA synthesis kit (Bio-Rad Laboratories) according to the manufacturer's instructions.
PCR amplification and real-time quantitation
Real-time PCR was performed using the iCycler Real-Time Detection System (iQ5 Bio-Rad) with optimized PCR conditions. The reaction was carried out in 96-well plate using iQ SYBR Green Supermix (Bio-Rad) adding forward and reverse primers for each gene and 1 ml of diluted template cDNA to a final reaction volume of 15 ml. All assays included a negative control and were replicated three times. The thermal cycling program was performed as follows: an initial denaturation step at 95 1C for 3 min, followed by 45 cycles at 95 1C for 10 s and 60 1C for 30 s. The PCR products were analyzed on a 2.0% agarose gel, stained with ethidium bromide and visualized under ultraviolet light. Copy numbers of 16E5 cDNA were determined as described (Fey et al., 2004) . Real-time quantitation was performed with the help of the iCycler IQ optical system software version 3.0a (Bio-Rad), according to the manufacturer's manual. The relative expression of the housekeeping gene was used for standardizing the reaction. The comparative threshold cycle (C t ) method was applied to calculate the fold changes of expression compared with control HaCaT cells transfected with the empty vector. Standard curves, generated using 10-fold serial dilutions of each DNA template, were used to quantitate the relative amount of 16E5 and b-actin mRNA. Results are reported as mean±s.d. from three different experiments in triplicate.
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